United Therapeutics Corporation

UTHR | NASDAQ

Price Alert Chart Builder DCF Calculator

$493.10

-$1.53 (-0.31%)

At close: Sep 21, 2026, 4:00 PM ET

$500

+$6.90 (+1.40%)

Pre-market: Sep 22, 2026, 8:55 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	1.33B	1.2B	984.8M	727.3M	475.8M	514.8M
Depreciation & Amortization	85.6M	72.5M	53.2M	51.3M	49.9M	49.9M
Stock-Based Compensation	147.7M	144M	39.1M	106.8M	138.5M	163.8M
Other Working Capital	-80.9M	-12.9M	-25.7M	-106.1M	-125.4M	58.8M
Other Non-Cash Items	2M	-24.3M	-1.3M	58.3M	108.2M	-35.9M
Deferred Income Tax	97.7M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-106.4M	-60.2M	-97.8M	-141.2M	-174.2M	63.1M
Operating Cash Flow	1.56B	1.33B	978M	802.5M	598.2M	755.7M
Capital Expenditures	-520.5M	-246.5M	-230.4M	-138.8M	-120.8M	-59.3M
Cash Acquisitions	n/a	-30.5M	-89.2M	-1.5M	n/a	n/a
Purchase of Investments	-3.46B	-1.65B	-2.51B	-1.71B	-1.9B	-2.31B
Sales Maturities Of Investments	1.58B	2.37B	2.14B	1.03B	1.53B	1.63B
Other Investing Acitivies	1.85B	-28.5M	-23M	3.5M	n/a	2.4M
Investing Cash Flow	-551.3M	417.2M	-719.6M	-811.5M	-486.9M	-738.5M
Debt Repayment	-300M	-400M	-100M	n/a	n/a	-50M
Common Stock Repurchased	-1B	-1.01B	-13.8M	-11.4M	-10.8M	-3.7M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-33.1M	157.4M	101.9M	86.8M	55.6M	36.8M
Financial Cash Flow	-1.15B	-1.25B	-11.9M	75.4M	44.8M	-16.9M
Net Cash Flow	-140.1M	489.5M	246.5M	66.4M	156.1M	300K
Free Cash Flow	1.04B	1.08B	747.6M	663.7M	477.4M	696.4M
Adj. Free Cash Flow	893M	936.6M	708.5M	556.9M	338.9M	532.6M
Maintenance CapEx	-375.22M	n/a	-57.63M	-33.14M	-38.69M	-45.75M
Growth CapEx	-145.28M	-246.5M	-172.77M	-105.66M	-82.11M	-13.55M
Owner Earnings	1.19B	1.33B	920.37M	769.36M	559.51M	709.95M